These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31230841)

  • 1. Clot activators do not expedite the time to predict massive transfusion in trauma patients analyzed with tissue plasminogen activator thrombelastography.
    Walker CB; Moore EE; Kam A; Dexter-Meldrum J; Nydam TL; Chapman MP; Chandler J; Sauaia A; Barrett CD; Yaffe MB; Moore HB
    Surgery; 2019 Sep; 166(3):408-415. PubMed ID: 31230841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmin thrombelastography rapidly identifies trauma patients at risk for massive transfusion, mortality, and hyperfibrinolysis: A diagnostic tool to resolve an international debate on tranexamic acid?
    Barrett CD; Moore HB; Vigneshwar N; Dhara S; Chandler J; Chapman MP; Sauaia A; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2020 Dec; 89(6):991-998. PubMed ID: 33230046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid TEG efficiently guides hemostatic resuscitation in trauma patients.
    Coleman JR; Moore EE; Chapman MP; Banerjee A; Silliman CC; Ghasabyan A; Chandler J; Samuels JM; Sauaia A
    Surgery; 2018 Sep; 164(3):489-493. PubMed ID: 29903508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viscoelastic Tissue Plasminogen Activator Challenge Predicts Massive Transfusion in 15 Minutes.
    Moore HB; Moore EE; Chapman MP; Huebner BR; Einersen PM; Oushy S; Silliman CC; Banerjee A; Sauaia A
    J Am Coll Surg; 2017 Jul; 225(1):138-147. PubMed ID: 28522144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?
    Moore HB; Moore EE; Chapman MP; Hansen KC; Cohen MJ; Pieracci FM; Chandler J; Sauaia A
    J Am Coll Surg; 2019 Jul; 229(1):92-101. PubMed ID: 30936005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence and magnitude of fibrinolytic activation in trauma patients.
    Raza I; Davenport R; Rourke C; Platton S; Manson J; Spoors C; Khan S; De'Ath HD; Allard S; Hart DP; Pasi KJ; Hunt BJ; Stanworth S; MacCallum PK; Brohi K
    J Thromb Haemost; 2013 Feb; 11(2):307-14. PubMed ID: 23176206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue plasminogen activator induced fibrinolysis: standardization of method using thromboelastography.
    Kupesiz A; Rajpurkar M; Warrier I; Hollon W; Tosun O; Lusher J; Chitlur M
    Blood Coagul Fibrinolysis; 2010 Jun; 21(4):320-4. PubMed ID: 20400895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe SARS-CoV-2 Infection Inhibits Fibrinolysis Leading to Changes in Viscoelastic Properties of Blood Clot: A Descriptive Study of Fibrinolysis in COVID-19.
    Hammer S; Häberle H; Schlensak C; Bitzer M; Malek NP; Handgretinger R; Lang P; Hörber S; Peter A; Martus P; Mirakaj V; Gawaz M; Geisler T; Althaus K; Rosenberger P; Bakchoul T
    Thromb Haemost; 2021 Nov; 121(11):1417-1426. PubMed ID: 33634444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Euglobulin clot lysis time reveals a high frequency of fibrinolytic activation in trauma.
    Ilich A; Kumar V; Ferrara MJ; Henderson MW; Noubouossie DF; Jenkins DH; Kozar RA; Park MS; Key NS
    Thromb Res; 2021 Aug; 204():22-28. PubMed ID: 34111811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous fibrinolytic potential in tissue-plasminogen activator-modified thromboelastography analysis is significantly decreased in dogs suffering from diseases predisposing to thrombosis.
    Spodsberg EH; Wiinberg B; Jessen LR; Marschner CB; Kristensen AT
    Vet Clin Pathol; 2013 Sep; 42(3):281-90. PubMed ID: 23944273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients.
    Moore HB; Moore EE; Chapman MP; Gonzalez E; Slaughter AL; Morton AP; D'Alessandro A; Hansen KC; Sauaia A; Banerjee A; Silliman CC
    J Thromb Haemost; 2015 Oct; 13(10):1878-87. PubMed ID: 26256459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue plasminogen activator challenge thrombelastography is the most accurate assay in predicting the need for massive transfusion in hypotensive trauma patients.
    Jiang JG; Moore HB; Moore EE; Pieracci F; Sauaia A
    Am J Surg; 2023 Dec; 226(6):778-783. PubMed ID: 37301646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation for effects of severe acidosis on hemostasis in trauma patients using thrombelastography analyzer.
    Lv X; Mao Y; Qin Z
    Am J Emerg Med; 2018 Aug; 36(8):1332-1340. PubMed ID: 29276028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dense and dangerous: The tissue plasminogen activator-resistant fibrinolysis shutdown phenotype is due to abnormal fibrin polymerization.
    Dow N; Coleman JR; Moore H; Osborn ZT; Sackheim AM; Hennig G; Butenas S; Nelson MT; Moore EE; Freeman K
    J Trauma Acute Care Surg; 2020 Feb; 88(2):258-265. PubMed ID: 31999655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actin is associated with tissue injury in trauma patients and produces a hypercoagulable profile in vitro.
    Coleman JR; Moore EE; Freeman K; Grubinger ND; Hennig GW; Cohen MJ; Samuels JM; Hansen K
    J Trauma Acute Care Surg; 2020 Jul; 89(1):87-95. PubMed ID: 32574484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The α-globin chain of hemoglobin potentiates tissue plasminogen activator induced hyperfibrinolysis in vitro.
    Morton AP; Hadley JB; Ghasabyan A; Kelher MR; Moore EE; Bevers S; Dzieciatkowska M; Hansen KC; Cohen MS; Banerjee A; Silliman CC
    J Trauma Acute Care Surg; 2022 Jan; 92(1):159-166. PubMed ID: 34538821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative effects of plasma, fibrinogen concentrate, and factor XIII on ROTEM coagulation profiles in an in vitro model of massive transfusion in trauma.
    Schmidt DE; Halmin M; Wikman A; Östlund A; Ågren A
    Scand J Clin Lab Invest; 2017 Oct; 77(6):397-405. PubMed ID: 28632435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective assessment of fibrinolysis in morbid obesity: tissue plasminogen activator resistance improves after bariatric surgery.
    Samuels J; Lawson PJ; Morton AP; Moore HB; Hansen KC; Sauaia A; Schoen JA
    Surg Obes Relat Dis; 2019 Jul; 15(7):1153-1159. PubMed ID: 31128997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy.
    Chapman MP; Moore EE; Ramos CR; Ghasabyan A; Harr JN; Chin TL; Stringham JR; Sauaia A; Silliman CC; Banerjee A
    J Trauma Acute Care Surg; 2013 Dec; 75(6):961-7; discussion 967. PubMed ID: 24256667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboelastography in patients with acute ischemic stroke.
    Elliott A; Wetzel J; Roper T; Pivalizza E; McCarthy J; Wallace C; Hess MJ; Peng H; Rahbar MH; Sangha N; Grotta JC
    Int J Stroke; 2015 Feb; 10(2):194-201. PubMed ID: 23017088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.